
|Videos|January 19, 2021
HER2+ BC: A Year in Review and Updates from SABCS
Author(s)Targeted Oncology
A review of key relevant data on HER2-positive breast cancer from the 2020 SABCS Virtual Symposium.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Fast Track Designation to VS-7375 for KRAS G12D–Mutated NSCLC
2
ASCO 2026 GI Cancer Highlights: Beyond the LBAs
3
ASCO 2026 GU Cancer Highlights: Beyond the LBAs
4
FDA Approves Generic Eribulin Mesylate for Metastatic Breast Cancer
5


































